Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe 650-0011, Japan.
World J Surg. 2012 Mar;36(3):593-7. doi: 10.1007/s00268-011-1391-1.
Therapeutic modified radical neck dissection (MND) is a mandatory surgical procedure for patients with papillary thyroid carcinoma (PTC) having clinical lateral node metastasis (N1b). However, N1b PTC is still likely to recur in regional lymph nodes after surgery. We investigated the clinicopathological features predicting recurrence in nodes in previously dissected compartments (ipsilateral lateral compartment or central compartment) and nodes in the contralateral lateral compartment for N1b patients who underwent unilateral therapeutic MND.
A total of 744 N1b PTC patients who underwent thyroidectomy with unilateral therapeutic MND between 1987 and 2004 were enrolled in the study. The patient ages ranged from 12 to 88 years (average 50.2 years). The average postoperative follow-up period was 113 months.
To date, 87 (12%) and 49 (7%) patients showed recurrence in previously dissected compartments and the contralateral lateral compartment, respectively. On univariate analysis, age >55 years, node metastasis >3 cm, extranodal tumor extension, and extrathyroid extension affected recurrence in previously dissected compartments. Also, the former two were independent predictors on multivariate analysis (P = 0.0170 and <0.0001, respectively). In contrast, only extrathyroid extension and tumor size >4 cm influenced recurrence in the contralateral lateral compartment on univariate analysis. On multivariate analysis, the former was an independent predictor (P = 0.0015), and the latter was of marginal significance (P = 0.0909). To date, 13% of patients having both of these characteristics showed recurrence in the contralateral lateral compartment.
Extremely careful therapeutic MND is required for N1b patients with age >55 years or node metastasis >3 cm because of the likelihood of recurrence in previously dissected compartments. Bilateral MND (therapeutic for ipsilateral side and prophylactic for contralateral side) may be a therapy option for N1b PTC >4 cm and having extrathyroid extension.
治疗性改良颈淋巴结清扫术(MND)是临床侧方淋巴结转移(N1b)的甲状腺乳头状癌(PTC)患者的强制性手术程序。然而,N1b PTC 患者在手术后仍有可能在区域淋巴结中复发。我们研究了预测先前清扫的侧方(同侧侧方或中央侧方)和对侧侧方淋巴结中复发的临床病理特征,这些患者均接受了单侧治疗性 MND。
共纳入 1987 年至 2004 年间接受单侧治疗性 MND 的甲状腺切除术的 744 例 N1b PTC 患者。患者年龄为 12 至 88 岁(平均 50.2 岁)。平均术后随访时间为 113 个月。
迄今为止,87 例(12%)和 49 例(7%)患者分别在前次清扫的部位和对侧侧方出现复发。单因素分析显示,年龄>55 岁、淋巴结转移>3cm、肿瘤外侵和甲状腺外侵犯影响前次清扫部位的复发。此外,这两个因素在多因素分析中均为独立预测因素(P=0.0170 和<0.0001)。相反,仅甲状腺外侵犯和肿瘤大小>4cm 在前次清扫的部位对复发有影响。多因素分析显示,前者是独立预测因素(P=0.0015),后者具有边缘意义(P=0.0909)。迄今为止,有这两个特征的患者中,13%在对侧侧方出现复发。
对于年龄>55 岁或淋巴结转移>3cm 的 N1b 患者,需要进行非常仔细的治疗性 MND,因为前次清扫的部位有复发的可能性。对于>4cm 且有甲状腺外侵犯的 N1b PTC,双侧 MND(同侧治疗性,对侧预防性)可能是一种治疗选择。